National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 5) (Cth)

Case

PB 76 of 2023

National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 5)

I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated      27 July 2023

NIKOLAI TSYGANOV

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2

1  Name

This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 5).

This instrument may also be cited as PB 76 of 2023.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1 Column 2 Column 3
Provisions Commencement Date/Details
1.  The whole of this instrument 1 August 2023

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under section 85B of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

  1. Schedule 1 – after entry for Brinzolamide

Insert

Budesonide with formoterol Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses Inhalation by nose Symbicort Turbuhaler 400/12 1 22.07 23.93
  1. Schedule 1 - entry for Verapamil

Omit

Verapamil Tablet containing verapamil hydrochloride 80 mg Oral Isoptin 100 6.16 9.04
Tablet containing verapamil hydrochloride 180 mg (sustained release) Oral Isoptin 180 SR 30 4.97 7.86
Tablet containing verapamil hydrochloride 240 mg (sustained release) Oral Isoptin SR 30 6.63 9.51

Insert

Verapamil Tablet containing verapamil hydrochloride 80 mg Oral Isoptin 100 6.16 9.04
Tablet containing verapamil hydrochloride 180 mg (sustained release) Oral Isoptin 180 SR 30 4.97 8.26
Tablet containing verapamil hydrochloride 240 mg (sustained release) Oral Isoptin SR 30 6.63 9.89
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0